 |
|
Partial Hepatectomy Augments the Liver's Antitumor Response
Ralph Doerr, MD;
Manuel Castillo, MD;
Paul Evans, MS;
Norman Paolini, MS;
Martin Goldrosen, PhD;
Stephan A. Cohen, PhD
Arch Surg. 1989;124(2):170-174.
Abstract
| |
• Despite adequate locoregional control, colorectal metastasis to the liver remains a significant cause of death. Resection of hepatic metastasis improves five-year survival 18% to 34%. A study of the impact of 40% partial hepatectomy on cytokine production in the liver was undertaken. Nonparenchymal liver cells (NPCs) were prepared by collagenase perfusion and metrizamide gradient from partially hepatectomized and laparotomized control C57BL/6Ros mice. Nonparenchymal cell from partially hepatectomized mice compared with laparotomized mice showed a twofold to threefold increase in interferon (IFN) activity. Both interferon alpha/beta and supernatants from cultured NPCs of partially hepatectomized mice suppressed the proliferation of liver-derived MCA-38 colon adenocarcinoma cells in vitro. This tumor has been shown to metastasize to the liver of C57BL/6Ros mice. The production of various cytokines by NPCs induced by partial hepatectomy may provide a possible antimetastatic mechanism.
(Arch Surg 1989;124:170-174)
Author Affiliations
From the Departments of Surgery (Drs Doerr and Castillo) and Medicine, Division of Gastroenterology and Hepatology (Dr Cohen and Mr Evans), State University of New York at Buffalo, Buffalo General Hospital, and the Department of Cell and Tumor Biology, Roswell Park Memorial Institute (Dr Goldrosen and Mr Paolini), Buffalo.
Footnotes
Accepted for publication Oct 12, 1988.
Read before the Annual Meeting of the Society of Surgical Oncology, New Orleans, May 23, 1988.
Reprint requests to Department of Surgery, Buffalo General Hospital, 100 High St, Buffalo, NY 14203 (Dr Doerr).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
|
